shutterstock_1821749396_rafapress
rafapress / Shutterstock.com
25 April 2023Big PharmaLiz Hockley

Cipla loses fightback over diarrhoea antibiotic

Judge rejects notion that tribunal acted unfairly in royalties dispute with Salix | Indian firm wanted payments on sales of antibiotic | Appeal brought under act with ‘high hurdle to surmount’.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
21 March 2023   Cipla claims Cabometyx patents are invalid | Exelixis wants generic blocked until at least 2030.
Generics
8 March 2022   Mumbai-based pharma company Cipla has filed a lawsuit asking a Delaware court to rule that its proposed generic of Boehringer Ingelheim’s lung disease treatment Ofev does not infringe two patents.